| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ANIKA THERAPEUTICS INC COM | 412,588 | 22,135,000 | 10.15% | ||
| 2 | GNC HLDGS INC | 681,955 | 16,565,000 | 7.60% | ||
| 3 | AMAG PHARMACEUTICALS INC COM | 671,585 | 16,064,000 | 7.37% | ||
| 4 | SUPERNUS PHARMACEUTICALS INC COM | 657,533 | 13,394,000 | 6.14% | ||
| 5 | TRIPLE S MGMT CORP CL B | 532,876 | 13,018,000 | 5.97% | ||
| 6 | MERCK & CO INC | 224,100 | 12,910,000 | 5.92% | ||
| 7 | CENCORA | 160,000 | 12,691,000 | 5.82% | ||
| 8 | FEI COMPANY | 118,609 | 12,677,000 | 5.81% | ||
| 9 | TARO PHARMACEUTICAL INDS LTD | 86,205 | 12,551,000 | 5.76% | ||
| 10 | CARDINAL HEALTH INC | 160,000 | 12,482,000 | 5.72% | ||
| 11 | CHARLES RIV LABS INTL INC | 149,612 | 12,334,000 | 5.66% | ||
| 12 | ANTHEM INC | 93,900 | 12,333,000 | 5.66% | ||
| 13 | LIFEPOINT HOSPS INC | 185,851 | 12,149,000 | 5.57% | ||
| 14 | CONCORDIA INTERNATIONAL CORP COM | 543,000 | 11,696,000 | 5.36% | ||
| 15 | INC Research Holdings Inc | 286,270 | 10,915,000 | 5.00% | ||
| 16 | INSYS THERAPEUTICS INC NEW COM NEW | 788,175 | 10,199,000 | 4.68% | ||
| 17 | ORASURE TECHNOLOGIES INC | 475,771 | 2,812,000 | 1.29% | ||
| 18 | IMMUCELL CORP | 168,323 | 1,161,000 | 0.53% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-018520, filed 2016.07.26).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
